Guangdong Association of Clinical Trials

Guangzhou, Guangdong

Oncologygene editingPhase II

Compare Sign in to watch

What changed

Phase I trial registered: Allogeneic WTX-212C in Advanced Solid Tumors

5d agoTrial registeredJul 14, 2026Source filing (opens the source filing in a new tab)

Momentum

100no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

914 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
EARLY_PHASE1 registered
Jun 26, 2026
Advanced Solid Tumors · RECRUITING · sponsor: Zhejiang Provincial People's Hospital · Allogeneic WTX-212C in Advanced Solid Tumors
ClinicalTrials.gov · NCT07556653 (opens the source filing in a new tab)
Trial
EARLY_PHASE1 registered
Jun 1, 2026
Autoimmune Diseases · NOT_YET_RECRUITING · sponsor: Chinese PLA General Hospital · Safety and Efficacy of KSVCBD Injection in Autoimmune Diseases
ClinicalTrials.gov · NCT07613411 (opens the source filing in a new tab)
Grant
R35 · $429k · non-dilutive
Mar 6, 2026
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LIU, YANG · NIGMS · award ends Feb 28, 2031 · Regulation of ER-phagy during cellular stresses
NIH RePORTER · NIH RePORTER 11272759 (opens the source filing in a new tab)
Trial
PHASE2 registered
Nov 5, 2025
NSCLC (Non-small Cell Lung Cancer), MRD, II-IIIB Stages, Adjuvant Immunotherapy · RECRUITING · sponsor: Guangdong Association of Clinical Trials · Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)
ClinicalTrials.gov · NCT07120698 (opens the source filing in a new tab)
Trial
NA registered
Oct 7, 2025
ADHD - Attention Deficit Disorder With Hyperactivity, ADHD, ADHD - Combined Type, ADHD - Inattentive Type, ADHD Specifically With Executive Function Impairment · TERMINATED · sponsor: Wuhan Sports University · Research on the Development, Implementation Effect and Neural Mechanism of a Physical Intervention Program for College Students With ADHD Based on the Characteristics of Balance Dysfunction
ClinicalTrials.gov · NCT07499427 (opens the source filing in a new tab)
Trial
NA registered
Jun 26, 2025
Type 2 Diabetes · RECRUITING · sponsor: Second Xiangya Hospital of Central South University · Hybrid Closed-Loop for Perioperative Glycemic Control in T2DM With Parenteral Nutrition
ClinicalTrials.gov · NCT07121504 (opens the source filing in a new tab)
Grant
R01 · $614k · non-dilutive
Apr 1, 2025
CARNEGIE-MELLON UNIVERSITY · PI ZHAO, YONGXIN · NCI · award ends Mar 31, 2030 · Ultrahigh-throughput imaging of 3D tumor microenvironment at nanoscale
NIH RePORTER · NIH RePORTER 11310198 (opens the source filing in a new tab)
Trial
Study registered
Jul 30, 2024
Postoperative Delirium, Postoperative Neurocognitive Disorder, Surgery · RECRUITING · sponsor: Xuanwu Hospital, Beijing · Risk Warning Model of Postoperative Delirium and Long-term Cognitive Dysfunction in Elderly Patients
ClinicalTrials.gov · NCT06423547 (opens the source filing in a new tab)
Trial
PHASE1 registered
Jul 3, 2024
Gastric Cancer, Pancreas Adenocarcinoma · COMPLETED · sponsor: Zhejiang Provincial People's Hospital · Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer
ClinicalTrials.gov · NCT06464965 (opens the source filing in a new tab)
Grant
R35 · $385k · non-dilutive
Aug 1, 2023
UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI LIU, YANG · NIGMS · award ends May 31, 2028 · Mapping the Cellular Responses to DNA Double-Strand Breaks Using On-Demand CRISPR technologies and High-resolution Fluorescence Microscopy
NIH RePORTER · NIH RePORTER 11332555 (opens the source filing in a new tab)
Trial
NA registered
Jun 20, 2023
Essential Hypertension · COMPLETED · sponsor: Yi Yang · Efficacy and Safety of Remote Ischemic Conditioning in the Treatment of Essential Hypertension (RICBP-EH)
ClinicalTrials.gov · NCT05910242 (opens the source filing in a new tab)
Trial
NA registered
May 7, 2023
Transcranial Magnetic Stimulation · COMPLETED · sponsor: Yi Yang · Effects of Repetitive Transcranial Magnetic Stimulation on Cerebral Autoregulation in Patients With Acute Ischemic Stroke
ClinicalTrials.gov · NCT05843240 (opens the source filing in a new tab)
Grant
R01 · $526k · non-dilutive
Aug 9, 2022
EMORY UNIVERSITY · PI LIU, YANG · NIEHS · award ends Apr 30, 2027 · The impact of wildfire smoke exposure on cardiovascular health in the western US
NIH RePORTER · NIH RePORTER 11325067 (opens the source filing in a new tab)
Grant
R01 · $388k · non-dilutive
May 9, 2022
UNIVERSITY OF MINNESOTA · PI YANG, YI-MEI (AMY) · NIMH · award ends Feb 28, 2027 · Neurobiology of stress in the cerebellar circuitry
NIH RePORTER · NIH RePORTER 11323973 (opens the source filing in a new tab)
Trial
NA registered
Aug 1, 2013
Asthma · COMPLETED · sponsor: Shanghai University of Traditional Chinese Medicine · Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma
ClinicalTrials.gov · NCT01931696 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 81%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Investigators

The principal investigators named on the grants below. Each links to their federal grant record and every other company traced to their work.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Phase I trial registered: Allogeneic WTX-212C in Advanced Solid Tumors
5d agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Allogeneic WTX-212C in Advanced Solid Tumors
5d agoTrial recruitingSource (opens the source filing in a new tab)
Phase I trial registered: Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer
1w agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer
1w agoTrial completedSource (opens the source filing in a new tab)
NIH R01 · $0.5M · The impact of wildfire smoke exposure on cardiovascular health in the western US
5w agoGrant renewalSource (opens the source filing in a new tab)
Phase I trial registered: Safety and Efficacy of KSVCBD Injection in Autoimmune Diseases
7w agoTrial registeredSource (opens the source filing in a new tab)
NIH R35 · $0.4M · Mapping the Cellular Responses to DNA Double-Strand Breaks Using On-Demand CRISPR technologies and High-resolution Fluorescence Microscopy
7w agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.6M · Ultrahigh-throughput imaging of 3D tumor microenvironment at nanoscale
2mo agoGrant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: Research on the Development, Implementation Effect and Neural Mechanism of a Physical Intervention Program for College Students With ADHD Based on the Characteristics of Balance Dysfunction
3mo agoTrial registeredSource (opens the source filing in a new tab)
NIH R35 · $0.4M · Regulation of ER-phagy during cellular stresses
4mo agoNew grantSource (opens the source filing in a new tab)
Study registered, no phase assigned: Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma
4mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Clinical Assessment of Acupuncture for the Treatment of Chronic Asthma
4mo agoTrial completedSource (opens the source filing in a new tab)
NIH R01 · $0.4M · Neurobiology of stress in the cerebellar circuitry
4mo agoGrant renewalSource (opens the source filing in a new tab)
Phase II trial registered: Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)
6mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)
6mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Hybrid Closed-Loop for Perioperative Glycemic Control in T2DM With Parenteral Nutrition
11mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Hybrid Closed-Loop for Perioperative Glycemic Control in T2DM With Parenteral Nutrition
11mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Efficacy and Safety of Remote Ischemic Conditioning in the Treatment of Essential Hypertension (RICBP-EH)
Jun 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: Efficacy and Safety of Remote Ischemic Conditioning in the Treatment of Essential Hypertension (RICBP-EH)
Jun 2025Trial completedSource (opens the source filing in a new tab)
Study registered, no phase assigned: Effects of Repetitive Transcranial Magnetic Stimulation on Cerebral Autoregulation in Patients With Acute Ischemic Stroke
Apr 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: Effects of Repetitive Transcranial Magnetic Stimulation on Cerebral Autoregulation in Patients With Acute Ischemic Stroke
Apr 2025Trial completedSource (opens the source filing in a new tab)
Study registered, no phase assigned: Risk Warning Model of Postoperative Delirium and Long-term Cognitive Dysfunction in Elderly Patients
Apr 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Risk Warning Model of Postoperative Delirium and Long-term Cognitive Dysfunction in Elderly Patients
Apr 2025Trial recruitingSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Peer position

Grant to raise

EARLY_PHASE1 registered

EARLY_PHASE1 registered

R35 · $429k · non-dilutive

PHASE2 registered

NA registered

NA registered

R01 · $614k · non-dilutive

Study registered

PHASE1 registered

R35 · $385k · non-dilutive

NA registered

NA registered

R01 · $526k · non-dilutive

R01 · $388k · non-dilutive

NA registered